- Home
- APLT vs RZLV Comparison
APLT vs RZLV Comparison
Compare APLT & RZLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- RZLV
- Stock Information
- Founded
- APLT 2016
- RZLV 2016
- Country
- APLT United States
- RZLV United Kingdom
- Employees
- APLT N/A
- RZLV N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- RZLV
- Sector
- APLT Health Care
- RZLV
- Exchange
- APLT Nasdaq
- RZLV NYSE
- Market Cap
- APLT 52.9M
- RZLV 514.1M
- IPO Year
- APLT 2019
- RZLV N/A
- Fundamental
- Price
- APLT $0.33
- RZLV $2.83
- Analyst Decision
- APLT Buy
- RZLV Strong Buy
- Analyst Count
- APLT 7
- RZLV 5
- Target Price
- APLT $6.10
- RZLV $5.20
- AVG Volume (30 Days)
- APLT 2.3M
- RZLV 10.8M
- Earning Date
- APLT 08-06-2025
- RZLV 02-21-2025
- Dividend Yield
- APLT N/A
- RZLV N/A
- EPS Growth
- APLT N/A
- RZLV N/A
- EPS
- APLT N/A
- RZLV N/A
- Revenue
- APLT $265,000.00
- RZLV $187,788.00
- Revenue This Year
- APLT $1,768.13
- RZLV $18,916.66
- Revenue Next Year
- APLT $292.85
- RZLV $175.14
- P/E Ratio
- APLT N/A
- RZLV N/A
- Revenue Growth
- APLT N/A
- RZLV 29.46
- 52 Week Low
- APLT $0.30
- RZLV $1.07
- 52 Week High
- APLT $10.62
- RZLV $12.29
- Technical
- Relative Strength Index (RSI)
- APLT 43.25
- RZLV N/A
- Support Level
- APLT $0.30
- RZLV N/A
- Resistance Level
- APLT $0.36
- RZLV N/A
- Average True Range (ATR)
- APLT 0.03
- RZLV 0.00
- MACD
- APLT -0.00
- RZLV 0.00
- Stochastic Oscillator
- APLT 22.22
- RZLV 0.00
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About RZLV REZOLVE AI LTD
Rezolve AI PLC is an AI-powered solutions company, specializing in enhancing customer engagement, operational efficiency, and revenue growth for the retail and e-commerce sectors. The company's product, Brain Commerce, powered by its proprietary Large Language Model (LLM) brainpowa, transforms the online shopping experience. By surpassing traditional site search and product discovery tools, Brain Commerce improves conversion rates, increases average order value (AOV), and reduces cart abandonment. The company has one reportable segment, which is cloud-based services. Geographically, the company generates revenue from Canada, the United States, Mexico, Australia, the United Kingdom, and Japan, with the majority of revenue generated from the United States.